Discover how the ARHGAP6 gene is revolutionizing acute myeloid leukemia research, serving as both a prognostic biomarker and potential therapeutic target.
Exploring RIOK2 as an emerging therapeutic target for acute myeloid leukemia and other cancers through ribosome biogenesis inhibition.